Saint Vincent and the Grenadines
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Saint Vincent and the Grenadines (VC)
2011 | 5.8 thousand |
2024 | 6.4 thousand |
2050 | 7.4 thousand |
Saint Vincent and the Grenadines is one of the 22 countries and territories in the IDF North America and Caribbean Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS 2014
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 5.8 | 6.4 | 7.4 |
Age-standardised prevalence of diabetes, % | - | 8.8 | 8.6 | 9.5 |
Proportion of people with undiagnosed diabetes, % | - | - | 24.5 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 1.6 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 1.9 | 2.2 |
Age-standardised prevalence of IFG, % | - | - | 2.5 | 2.8 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 7.3 | 4.0 | 4.6 |
Age-standardised prevalence of IGT, % | - | 10.9 | 5.3 | 6.0 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 78.0 | 104.5 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 13.7 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 5.9 | 6.4 |
Total diabetes-related health expenditure, ID million | - | - | 9.8 | 10.7 |
Diabetes-related health expenditure per person, USD | - | 395.0 | 913.1 | 865.6 |
Diabetes-related health expenditure per person, ID | - | - | 1,524.1 | 1,444.9 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 72.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 18.1 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 68.8 | 71.7 | 73.0 |
Population of children and adolescents (0-19 y) | - | - | 28,788.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |